Physician profile
Saba Lahsaei
NPI 1205141322
$33,906.30
in general payments reported to CMS, 2019-2025
54 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $1,199 · 2021: $2,935 · 2022: $2,430 · 2023: $20K · 2024: $3,186 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $9,999 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,300 · Travel and Lodging: $165 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,800.00 |
| Food and Beverage | $9,998.58 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,300.00 |
| Travel and Lodging | $165.32 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $15,279.39 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $3,486.38 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $2,411.84 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Selectra |
| Novartis Pharmaceuticals Corporation | $959.68 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $876.52 | 2019-2025 | Lifevest |
| Amgen INC. | $818.10 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $695.84 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $643.28 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $641.81 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $626.74 | 2020-2025 | Amplatzer Amulet, Merlin@Home, Emboshield Nav6 |
| Boston Scientific Corporation | $583.52 | 2021-2025 | Ranger, Jetstream Sc, Eluvia |
| Merck Sharp & Dohme LLC | $580.16 | 2021-2025 | Verquvo, Capvaxive |
| Edwards Lifesciences Corporation | $537.24 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $413.74 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $384.11 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $368.10 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $366.80 | 2022-2025 | |
| Abiomed | $334.74 | 2019-2025 | Impella |
| Inquis Medical, INC. | $333.06 | 2024-2025 | Aventus |
| Astrazeneca Pharmaceuticals LP | $316.01 | 2020-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.17 | 2019-2025 | Jardiance |
| Atricure, INC. | $261.09 | 2022-2025 | Atriclip Laa Exclusion System |
| Philips North America LLC | $246.17 | 2020-2025 | (5044) Mcot, (5091) Amb Mon & Diag Und, Mcot |
| Impulse Dynamics (USA) INC. | $242.48 | 2023 | Optimizer |
| Astellas Pharma US INC | $220.70 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $189.51 | 2021-2023 | Arcalyst |
| Medtronic, INC. | $168.82 | 2021-2025 | In.Pact Admiral, Venaseal |
| Stryker Corporation | $142.46 | 2025 | Flowtriever, Artix Mt |
| Medtronic Vascular, INC. | $141.20 | 2019 | |
| Cathworks, INC. | $117.54 | 2019-2022 | |
| Ethicon US, LLC | $111.45 | 2020-2024 | Surgicel Nu-Knit |
| Lexicon Pharmaceuticals, INC. | $110.18 | 2023-2024 | Inpefa |
| Baxter Healthcare | $102.60 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Ekos Corporation | $88.79 | 2019 | |
| Viz.Ai, INC. | $86.51 | 2022 | |
| Kestra Medical Technology Services, INC. | $78.57 | 2024 | Assure Wcd |
| Scpharmaceuticals INC. | $74.33 | 2023-2024 | |
| Biosense Webster, INC. | $71.19 | 2023-2024 | Carto 3, Qdot Micro Catheter |
| Chiesi USA, INC. | $66.49 | 2020-2023 | Kengreal, Cleviprex |
| Braemar Manufacturing, LLC | $58.62 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $57.13 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $49.55 | 2022-2025 | Amvuttra |
| Cardiovascular Systems INC. | $45.33 | 2022 | |
| Bardy Diagnostics, INC. | $33.40 | 2022 | |
| Angiodynamics, INC. | $30.09 | 2022-2023 | Alphavac |
| Terumo Medical Corporation | $28.99 | 2024 | Azur Cx Detachable |
| Heartflow, INC. | $27.50 | 2024 | |
| Penumbra, INC. | $25.15 | 2024 | Indigo System |
| Genzyme Corporation | $21.04 | 2022 | |
| Bard Peripheral Vascular, INC. | $20.06 | 2021 | |
| Lantheus Medical Imaging, INC. | $19.55 | 2020 | |
| Novo Nordisk INC | $14.02 | 2023 | Rybelsus, Ozempic |
| Tactile Systems Technology INC | $12.03 | 2022 | |
| Reflow Medical INC | $7.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Lahsaei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.